These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19245939)

  • 41. Impact of iron chelators on growth and expression of iron-related genes of Cryptococcus species.
    Chayakulkeeree M; Tangkoskul T; Waywa D; Tiengrim S; Pati N; Thamlikitkul V
    J Mycol Med; 2020 Apr; 30(1):100905. PubMed ID: 31706700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune-Mediated Damage Completes the Parabola:
    Pirofski LA; Casadevall A
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cdk8 and Ssn801 Regulate Oxidative Stress Resistance and Virulence in Cryptococcus neoformans.
    Chang AL; Kang Y; Doering TL
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755515
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cryptococcus species--etiological agents of zoonoses or sapronosis?].
    Blaschke-Hellmessen R
    Mycoses; 2000; 43 Suppl 1():48-60. PubMed ID: 11098627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cryptococcus neoformans and Cryptococcus gattii genes preferentially expressed during rat macrophage infection.
    Goulart L; Rosa e Silva LK; Chiapello L; Silveira C; Crestani J; Masih D; Vainstein MH
    Med Mycol; 2010 Nov; 48(7):932-41. PubMed ID: 20302549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The interplay of phenotype and genotype in Cryptococcus neoformans disease.
    Altamirano S; Jackson KM; Nielsen K
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33021310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of cryptococcal virulence and persistence.
    Olszewski MA; Zhang Y; Huffnagle GB
    Future Microbiol; 2010 Aug; 5(8):1269-88. PubMed ID: 20722603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms.
    Rodrigues ML; Alviano CS; Travassos LR
    Microbes Infect; 1999 Apr; 1(4):293-301. PubMed ID: 10602663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histopathological study of murine pulmonary cryptococcosis induced by Cryptococcus gattii and Cryptococcus neoformans.
    Okubo Y; Wakayama M; Ohno H; Yamamoto S; Tochigi N; Tanabe K; Kaneko Y; Yamagoe S; Umeyama T; Shinozaki M; Nemoto T; Nakayama H; Sasai D; Ishiwatari T; Shimodaira K; Yamamoto Y; Kamei K; Miyazaki Y; Shibuya K
    Jpn J Infect Dis; 2013; 66(3):216-21. PubMed ID: 23698482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective involvement of the brain in experimental murine cryptococcosis. II. Histopathological observations.
    Grosse G; Mishra SK; Staib F
    Zentralbl Bakteriol Orig A; 1975 Sep; 233(1):106-22. PubMed ID: 1106066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New weapons in the Cryptococcus infection toolkit.
    Taylor-Smith LM; May RC
    Curr Opin Microbiol; 2016 Dec; 34():67-74. PubMed ID: 27522351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular typing and in vitro antifungal susceptibility of Cryptococcus spp from patients in Midwest Brazil.
    Favalessa OC; de Paula DA; Dutra V; Nakazato L; Tadano T; Lazera Mdos S; Wanke B; Trilles L; Walderez Szeszs M; Silva D; Hahn RC
    J Infect Dev Ctries; 2014 Aug; 8(8):1037-43. PubMed ID: 25116671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.
    Capilla J; Maffei CM; Clemons KV; Sobel RA; Stevens DA
    Med Mycol; 2006 Nov; 44(7):601-10. PubMed ID: 17071553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
    Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
    Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii.
    Jain N; Fries BC
    Mycopathologia; 2008 Oct; 166(4):181-8. PubMed ID: 18568418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology.
    Hoang LMN; Maguire JA; Doyle P; Fyfe M; Roscoe DL
    J Med Microbiol; 2004 Sep; 53(Pt 9):935-940. PubMed ID: 15314203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Monothiol Glutaredoxin Grx4 Regulates Iron Homeostasis and Virulence in Cryptococcus neoformans.
    Attarian R; Hu G; Sánchez-León E; Caza M; Croll D; Do E; Bach H; Missall T; Lodge J; Jung WH; Kronstad JW
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Urease activity in Cryptococcus neoformans and Cryptococcus gattii].
    Torres-Rodríguez JM; Alvarado-Ramírez E; Gutiérrez-Gallego R
    Rev Iberoam Micol; 2008 Mar; 25(1):27-31. PubMed ID: 18338924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
    Chan M; Lye D; Win MK; Chow A; Barkham T
    Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation and purification of antigenic components of Cryptococcus.
    Wozniak KL; Levitz SM
    Methods Mol Biol; 2009; 470():71-83. PubMed ID: 19089377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.